Systematic review finds no evidence for a best injection day

A systematic review published August 10, 2026, in the journal Medicina looked for evidence on whether a particular day of the week produces better results from once-weekly semaglutide or tirzepatide injections. The researchers, from the University of Catania, found no such evidence exists ^[1].

The team searched SciSpace, Google Scholar, and PubMed through June 2026, following PRISMA 2020 guidelines for systematic reviews ^[1]. They started with 1,471 identified records, which narrowed to 1,000 unique papers after removing duplicates ^[1]. After a two-stage screening process, only three studies met the inclusion criteria ^[1].

Those three studies were the SUSTAIN 4 randomized controlled trial of once-weekly injectable semaglutide, a retrospective case series on alternate-day oral semaglutide dosing, and an expert panel discussion about flexible dosing schedules ^[1]. None of the three directly compared outcomes for different days of the week, and the reviewers state plainly that "no studies directly compared different days of the week for injectable semaglutide or tirzepatide administration" ^[1].

Based on the limited and indirect evidence available, the authors concluded that flexible dosing schedules "may support adherence and tolerability without compromising glycemic control," but they caution this idea comes mainly from indirect evidence and expert opinion rather than direct comparative clinical trials ^[1]. Their bottom line: "Current evidence does not support a specific optimal day of the week for semaglutide or tirzepatide administration" ^[1]. Instead, the paper says the limited literature supports schedules tailored to a patient's own preferences and lifestyle, to help people stick with treatment over time ^[1].

Why it matters for patients

Semaglutide (sold as Ozempic, Wegovy, and Rybelsus) and tirzepatide (sold as Mounjaro and Zepbound) are typically dosed once a week for the injectable forms. Some patients and clinicians have wondered whether picking a specific day — say, to align with a weekend or a lighter meal schedule — might improve blood sugar control, weight loss, or side effects. This review says that idea is not supported by direct research ^[1].

For people currently on these medications, the finding suggests there is no scientific reason from the available data to believe one day of the week works better than another for the drug itself. The authors' emphasis on flexibility implies that choosing an injection day based on what fits a person's routine — rather than trying to chase a supposed optimal day — is more consistent with what little evidence exists ^[1]. That could matter for adherence, since missing or delaying doses is a common real-world challenge with weekly injectables.

It's worth being clear about what this review does and does not show. It is not a new clinical trial testing different days head-to-head. It is a review that searched the literature and found almost nothing on the topic: just three studies, none of which was designed to answer the question directly ^[1]. The near-total absence of research means the honest answer here is that scientists simply don't know yet whether timing within the week matters, not that flexible dosing has been proven equally effective across the board.

What happens next

The review's authors call for future prospective studies that would systematically test whether the day of administration affects glycemic control, weight loss, adherence, or side effects in real-world settings ^[1]. No such trials are described as underway in this paper, so any answer to the underlying question remains a matter for future research rather than current fact ^[1].